GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zydus Lifesciences Ltd (BOM:532321) » Definitions » Market Cap

Zydus Lifesciences (BOM:532321) Market Cap : ₹1,065,149 Mil (As of May. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Zydus Lifesciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zydus Lifesciences's share price for the quarter that ended in Mar. 2024 was ₹1005.25. Zydus Lifesciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 1,006 Mil. Therefore, Zydus Lifesciences's market cap for the quarter that ended in Mar. 2024 was ₹1,011,513 Mil.

Zydus Lifesciences's quarterly market cap increased from Sep. 2023 (₹622,655 Mil) to Dec. 2023 (₹697,456 Mil) and increased from Dec. 2023 (₹697,456 Mil) to Mar. 2024 (₹1,011,513 Mil).

Zydus Lifesciences's annual market cap increased from Mar. 2022 (₹356,978 Mil) to Mar. 2023 (₹497,496 Mil) and increased from Mar. 2023 (₹497,496 Mil) to Mar. 2024 (₹1,011,513 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zydus Lifesciences's Enterprise Value for Today is ₹1,053,042 Mil.


Zydus Lifesciences Market Cap Historical Data

The historical data trend for Zydus Lifesciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zydus Lifesciences Market Cap Chart

Zydus Lifesciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 273,440.95 451,315.78 356,978.14 497,496.30 1,011,512.71

Zydus Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 497,496.30 589,859.55 622,654.83 697,456.41 1,011,512.71

Competitive Comparison of Zydus Lifesciences's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Zydus Lifesciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zydus Lifesciences's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zydus Lifesciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Zydus Lifesciences's Market Cap falls into.



Zydus Lifesciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Zydus Lifesciences's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹1005.25*1006.23
=₹1,011,513

Zydus Lifesciences's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₹1005.25*1006.23
=₹1,011,513

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zydus Lifesciences  (BOM:532321) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Zydus Lifesciences Market Cap Related Terms

Thank you for viewing the detailed overview of Zydus Lifesciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Zydus Lifesciences (BOM:532321) Business Description

Traded in Other Exchanges
Address
Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481
Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.

Zydus Lifesciences (BOM:532321) Headlines

No Headlines